Register to leave comments

  • News bot Aug. 20, 2026, 8:34 p.m.

    🔍 Parisotto Shannon M (Executive)

    Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

    Report Date: 2026-08-19

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 1
    • Holdings reported: 2
    • Total shares acquired: 2,039
    • Total shares sold: 4,078
    • Total shares held: 38,190

    Detailed Transactions and Holdings:

    • Acquired 2,039 shares of Common Stock at $194.12 per share (Direct)
      Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | shares_owned_after: 6,846.00 | transaction_form_type: 4
    • Sold 2,039 shares of Common Stock at $294.12 per share (Direct)
      Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,807.00 | transaction_form_type: 4 | Footnotes: F1
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-19 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 9,680.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-19 | Code: H | nature_of_ownership: by Karpathos Investments LLC | shares_owned_after: 28,510.00
    • Sold 2,039 shares of Stock Options (Right to Buy) at $194.12 per share (Derivative)
      Date: 2026-08-19 | Code: M | Expires: 2033-05-26 | Exercise: 2024-05-26 | equity_swap_involved: 0 | shares_owned_after: 2,039.00 | transaction_form_type: 4

    Footnotes:

    • F1: This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026.